
Cesar Rodriguez Valdes MD
Hematologic Oncology
Assistant Professor, Myeloma and plasma cell disorders program Director, Associate Director Maya Angelou Center for Health Equity, Wake Forest School of Medicine, Comprehensive Cancer Center
Join to View Full Profile
10 E 102nd StNew York, NY 10029
Phone+1 212-241-6756
Dr. Rodriguez Valdes is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am a myeloma specialist in charge of clinical and transactional research for the Myeloma Program at Wake Forest University. I do clinical care including stem cell transplants and cell therapy. My translational research focus is on myeloma organoids to understand chemoresistance.
Education & Training
- University of Louisville School of MedicineFellowship, Hematology and Medical Oncology, 2009 - 2012
- Texas Tech University HSC El PasoResidency, Internal Medicine, 2006 - 2009
- Monterrey Inst TechClass of 2005
- ITESM MD
Certifications & Licensure
- FL State Medical License 2022 - Present
- NY State Medical License 2021 - 2026
- NC State Medical License 2015 - 2021
- KY State Medical License 2009 - 2016
- SC State Medical License 2008 - 2013
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- Top 40 under 40 Business Insider, 2015
- National Patient's Choice Award 2014
- Leukemia and Lymphoma Society Man of the Year LLS, 2014
- Join now to see all
Clinical Trials
- A-dmDT390-bisFv(UCHT1) Immunotoxin Therapy for Patients With Cutaneous T-Cell Lymphoma (CTCL) Start of enrollment: 2008 Jan 01
- A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Overcoming Chemotherapy Resistance In Refractory Multiple Myeloma With Simvastatin and Zoledronic Acid Start of enrollment: 2012 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 21 citationsSequencing T-cell redirection therapies leads to deep and durable responses in patients with relapsed/refractory myeloma.Tarek H Mouhieddine, Oliver Van Oekelen, David T Melnekoff, Jeanne Li, Yogita Ghodke-Puranik
Blood Advances. 2023-03-28 - 45 citationsInterventions and outcomes of patients with multiple myeloma receiving salvage therapy after BCMA-directed CAR T therapy.Oliver Van Oekelen, Karthik Nath, Tarek H Mouhieddine, Tasmin Farzana, Adolfo Aleman
Blood. 2023-02-16 - 1 citationsBridging advanced myeloma patients to subsequent treatments and clinical trials with classical chemotherapy and stem cell support.Tarek H Mouhieddine, Erin Moshier, Santiago Thibaud, Benjamin Puliafito, Mohammad Rattu
Bone Marrow Transplantation. 2023-01-01
Journal Articles
- KLF9-dependent ROS regulate melanoma progression in stage-specific MannerM Nikiforov, A Bagati, S Moparthy, E Fink, A Bianchi-Smiraglia, D Yun, M Kolesnikova, O Udartseva, D Wolff, M Roll, B Lipchik, N Kozlova, P Jowdy, A Berman, N Box, ES ..., Oncogene, 1/21/2019
- Paraproteinemia and serum protein electrophoresis interpretationSK Raj, B Guha, C Rodriguez, B Krishnaswamy, Ann Allrgy Asthma Immunol, 1/1/2019
- Guidance from ASMBT Practice Guidelines Committee for establishing a long term follow-up clinic for hematopoietic cell transplant survivorsSK Hashmi, SJ Lee, BN Savani, L Burns, JR Wingard, MA Perales, J Palmer, E Chow, E Meyer, D Marks, M Mohty, Y Inamoto, C Rodriguez, JD Rizzo, PA Carpenter, BBMT, 1/30/2018
- Join now to see all
Abstracts/Posters
- Model of patient-specific multiple myeloma 3D printed organodis for predicting chemotherapy response: feasibility Study.J Aleman, A Maycock, S George, C Porada, G Almeida-Porada, C Rodriguez, A Skardal, NCTERMS, 1/23/2019
- Assessment of treatment-related effects on cognition in multiple myeloma patients undergoing autologous stem cell transplant.*M Tam, E Dressler, K Duckworth, C Rodriguez, Women�s Health Research Day, 1/17/2019
- Tacrolimus levels and correlation to age and weight calculation.Seegars MB, Isom S, Kennedy L, Anders B, Rodriguez C, ASBMT Oral and Poster Session II, Salt Lake City, 2/24/2018
- Join now to see all
Lectures
- Emerging Small Molecules in Multiple MyelomaAtrium Health, Charlotte, NC - 1/11/2019
- Insights into Managing MyelomaCary, NC - 1/7/2019
- MNI Great Lakes Bone Health ECHO, Paraprotein Screening in Osteoporosis PatientsMichigan - 1/27/2018
- Join now to see all
Other
- (Featured article) Featured article on the research I am doing regarding 3D myeloma cultures.Valdes CR, MD Anderson: The Multiple Myeloma Daily
1/23/2019 - Report on immunotherapy for myeloma treatment using first-in-human BiTE clinical trials at Wake Forest.Valdes CR, WXII News
1/22/2018 - (Featured documentary) Participated on a documentary focused on myeloma awareness and the milestones in treatment thanks to ongoing research.Valdes CR, Cures Magazine
1/9/2018 - Join now to see all
Press Mentions
- International Myeloma Foundation Medical Student Scholars for Health Equity in Myeloma Present Posters at the 2024 NMA Annual Convention & Scientific AssemblyAugust 15th, 2024
Grant Support
- Young InvestigatorCTSIPresent
- Translational Research in MyelomaMyeloma Crowd Research InitiativePresent
Committees
- member, CTN MRD and immune profiling 2016 - Present
- member, CTN myeloma committee 2015 - Present
- member, ASBMT Practice Guidelines 2015 - Present
Research History
- Multiple Myeloma and Plasma Cell Disorders Lead2015 - Present
Professional Memberships
- Member
- Member
Other Languages
- French, Italian, Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: